EGRX EV/EBITDA

22328.3%

Upside

As of 2026-04-09, the EV/EBITDA ratio of Eagle Pharmaceuticals Inc (EGRX) is 0.67. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EGRX's latest enterprise value is 59.23 mil USD. EGRX's TTM EBITDA according to its financial statements is 87.82 mil USD. Dividing these 2 quantities gives us the above EGRX EV/EBITDA ratio.

	Range	Selected
Trailing P/E multiples	12.1x - 15.4x	14.6x
Forward P/E multiples	14.4x - 17.1x	15.6x
Fair Price	31.87 - 58.57	44.86
Upside	15834.5% - 29186.9%	22328.3%

0.20 USD

Stock Price

44.86 USD

Fair Price

EGRX EV/EBITDA - Historical EV/EBITDA Data

Date	EV/EBITDA
2026-04-06	0.67
2026-04-02	0.69
2026-04-01	0.65
2026-03-26	0.71
2026-03-24	0.66
2026-03-19	0.65
2026-03-17	0.63
2026-03-16	0.62
2026-03-09	0.71
2026-03-02	0.66
2026-02-27	0.66
2026-02-26	0.67
2026-02-19	0.67
2026-02-13	0.69
2026-02-12	0.69
2026-02-09	0.69
2026-02-06	0.69
2026-02-05	0.69
2026-02-03	0.69
2026-01-30	0.69
2026-01-27	0.71
2026-01-21	0.80
2026-01-16	0.75
2026-01-14	0.84
2026-01-13	0.71
2026-01-12	0.71
2026-01-08	0.72